Cimetidine: A review of the recent developments and reports in cutaneous medicine

Dermatology Online Journal

Volumn 9, Issue 2, 2003, Pages 47-57

  Scheinfeld, Noah ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CETIRIZINE; CHLOROQUINE; CIMETIDINE; CLARITHROMYCIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DAPSONE; DIMAPRIT; DIPHENHYDRAMINE; HYDROXYZINE; INTERLEUKIN 6; METOPROLOL; NIFEDIPINE; PLACEBO; PROPRANOLOL; PYRIMETHAMINE; QUINIDINE; THEOPHYLLINE;

ACUTE INTERMITTENT PORPHYRIA; AMINOTRANSFERASE BLOOD LEVEL; APHTHOUS STOMATITIS; BURN; CLINICAL TRIAL; CONDYLOMA; CONFUSION; CREATININE BLOOD LEVEL; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; DOSE RESPONSE; DRUG ERUPTION; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; DRUG WITHDRAWAL; ENZYME INHIBITION; EOSINOPHILIC FASCIITIS; FEVER; GYNECOMASTIA; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; MASTOCYTOSIS; MELANOMA; MESENTERIC LYMPHADENITIS; MOLLUSCUM CONTAGIOSUM; NONHUMAN; PAPILLOMATOSIS; PERIODIC FEVER APTHOUS STOMATITIS PHARYNGITIS ADENITIS SYNDROME; PHARYNGITIS; PRURITUS; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SINUS BRADYCARDIA; SOMNOLENCE; STOMACH ACID SECRETION; URTICARIA; VERRUCA VULGARIS;

EID: 3042685101     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Aram H. Cimetidine in dermatology. Int J Dermatol 1987;26:161-6.
2. 2 receptor antagonists, cromolyn sodium, and ketotifen. Clin Dermatol 2000;18:103-11.
3. 2-receptor antagonists. Clin Pharmacol Ther 1999;65:369-76.
4. Levine M, Law EY, Bandiera SM, Chang TK, Bellward GD. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats. J Pharmacol Exp Ther 1998;284:493-9.
5. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998;18:84-112.
6. Wolverton SE. Hepatotoxicity of Drug Therapy p.780-797 in Comprehensive Dermatologic Drug Therapy SE Wolverton ed. W.B. Saunders Philadelphia 2001.
7. Bormann G, Gaber G, Fischer M, Marsch WC. Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 2001;15:465-7.
8. Amsden GW, Cheng KL, Peloquin CA, Nafziger AN. Oral cimetidine prolongs clarithromycin absorption. Antimicrob Agents Chemother 1998;42:1578-80.
9. Paciorkowski A, Dai WW, Cerami A, Berger BJ. Synergism of cimetidine with anti-malarial agents. J Parasitol 1997;83:960-3.
10. Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, Johansson S. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999;150:476-81.
11. Kohda F, Koga T, Uchi H, Urabe K, Furue M. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J Dermatol Sci 2002;28:34-41.
12. 2 antagonist cimetidine on the numbers of CD4+ and CD8+ cells in the nasal mucosa of patients with allergic rhinitis. Clin Otolaryngol 1997;22:93-5.
13. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions. Anesth Analg 1999;89:218-24.
14. Hunter RP, Short CR, McClure JR, Koch CE, Keowen ML, VanSteenhouse JL, Dees AA. Cimetidine inhibits nitric oxide associated nitrate production in a soft-tissue inflammation model in the horse. J Vet Pharmacol Ther 1999;22:136-47.
15. Shinoda S, Kameyoshi Y, Hide M, Morita E, Yamamoto S. Histamine enhances UVB-induced IL-6 production by human keratinocytes. Arch Dermatol Res 1998;290:429-34.
16. 2 receptor is linked to cell proliferation and c-fos gene transcription. Am J Physiol 1997 Dec;273:C2037-45.
17. Hewitt P, Armstrong N, Bowrey P, Cherian M, Morris D. Cimetidine prevents suppression of delayed hypersensitivity in an animal model of haemorrhagic shock. Injury 2002;33:673.
18. Bigby M. Snake oil for the 21st century. Arch Dermatol 1998;134:1512-4.
19. Leman JA, Benton EC. Verrucas. Guidelines for management. Am J Clin Dermatol 2000;1:143-9.
20. Allen AL, Siegfried EC. What's new in human papillomavirus infection. Curr Opin Pediatr 2000;12:365-9.
21. Fischer G, Rogers M. Cimetidine therapy for warts in children. J Am Acad Dermatol 1997;37:289-90.
22. Gooptu C, Higgins CR, James MP. Treatment of viral warts with cimetidine: an open-label study. Clin Exp Dermatol 2000;25:183-5.
23. Rogers CJ, Gibney MD, Siegfried EC, Harrison BR, Glaser DA. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol 1999;41:123-7.
24. Karabulut AA, Sahin S, Eksioglu M. Is cimetidine effective for nongenital warts: a double-blind, placebo-controlled study. Arch Dermatol 1997;133:533-4.
25. Micali G, Nasca MR, Dall'Oglio F, Musumeci ML. Cimetidine therapy for epidermodysplasia verruciformis. J Am Acad Dermatol 2003;48:S9-10.
26. Parsad D, Saini R, Negi KS. Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts. Australas J Dermatol 1999;40:93-5.
27. Parsad D, Pandhi R, Juneja A, Negi KS. Cimetidine and levamisole versus cimetidine alone for recalcitrant warts in children. Pediatr Dermatol 2001;18:349-52.
28. Franco I. Oral cimetidine for the management of genital and perigenital warts in children. J Urol 2000;164:1074-5.
29. Harcourt JP, Worley G, Leighton SE. Cimetidine treatment for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 1999;51:109-13.
30. Shields CL, Lally MR, Singh AD, Shields JA, Nowinski T.Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis. Am J Ophthalmol 1999;128:362-4.
31. Yashar SS, Shamiri B. Oral cimetidine treatment of molluscum contagiosum. Pediatr Dermatol 1999;16:493.
32. Husar K, Skerlev. M. Molluscum contagiosum from infancy to maturity. Clin Dermatol 2002;20:170-2.
33. Sharma AK. Cimetidine therapy for multiple molluscum contagiosum lesions. Dermatology 1998;197:194-5.
34. Cunningham BB, Paller AS, Garzon M. Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum. Pediatr Dermatol 1998;15:71-2.
35. Negro-Alvarez JM, Miralles-Lopez JC. Chronic idiopathic urticaria treatment. Allergol Immunopathol (Madr) 2001;29:129-32.
36. Sharma JK, Miller R, Murray S. Chronic urticaria: a Canadian perspective on patterns and practical management strategies. J Cutan Med Surg 2000:4:89-93.
37. Lee EE, Maibach HI. Treatment of urticaria. An evidence-based evaluation of antihistamines. Am J Clin Dermatol 2001;2:27-32.
38. Skrebova N, Takiwaki H, Miyaoka Y, Arase S. Localized heat urticaria: a clinical study using laser Doppler flowmetry. J Dermatol Sci 200;26:112-8.
39. Mardones P, Moyano C, Pena K, Quijada C. Systemic mastocytosis: clinical case. Rev Med Chil 1998;126:823-7.
40. Guss DA. Scombroid fish poisoning: successful treatment with cimetidine. Undersea Hyperb Med 1998;25:123-5.
41. MacGillivray KC, Sweeney RW, Del Piero F. Metastatic melanoma in horses. J Vet Intern Med 2002;16:452-6.
42. Szincsak N, Hegyesi H, Hunyadi J, Martin G, Lazar-Molnar E, Kovacs P, Rivera E, Falus A, Juhasz I. Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line. Melanoma Res 2002;12:231-40.
43. Ristic B, Zecevic RD, Karadaglic DJ. Treatment of eosinophilic fasciitis with cimetidine. Vojnosanit Pregl 2001;58:437-40.
44. Rogers M. Successful treatment of eosinophilic pustulosis with oral cimetidine. Pediatr Dermatol 1999;16:335-6.
45. 2 antagonists. J Burn Care Rehabil 2001;22(4):263-8.
46. 2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 2001;116:261-5.
47. Lee WI, Yang MH, Lee KF, Chen LC, Lin SJ, Yeh KW, Huang JL. PFAPA syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis, Adenitis). Clin Rheumatol 1999;18:207-13.
48. Pillet P, Ansoborlo S, Carrere A, Perel Y, Guillard JM. (P)FAPA syndrome: value of cimetidine. Arch Pediatr 2000;7:54-7.
49. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 1999;135:15-21.
50. Schibler A, Birrer P, Vella S. PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis. Schweiz Med Wochenschr 1997;127:1280-4.
51. Sasaki H. A new approach for the treatment of acute porphyria. Intern Med 1999;38:307-8.
52. Rogers PD. Cimetidine in the treatment of acute intermittent porphyria. Ann Pharmacother 1997;31:365-7.
53. Coleman MD. Dapsone toxicity: some current perspectives. Gen Pharmacol 1995;26(7):1461-7.
54. Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf 1996;14(6):394-405.
55. Rhodes LE, Tingle MD, Park BK, Chu P, Verbov JL, Friedmann PS. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1995;132(2):257-62.
56. Coleman MD, Rhodes LE, Scott AK, Verbov JL, Friedmann PS, Breckenridge AM, Park BK. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992;34(3):244-9.
57. Malfara WR, Pereira CP, Santos AC, Queiroz RH. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats. Pharmacol Res 2002;45(4):269-73.
58. Evans RD, Yoho R, Eberly M, Donohoe S. Cimetidine and a delayed hypersensitivity reaction. Clin Podiatr Med Surg 2000;17:371-5.
59. Helmbold P, Hegemann B, Dickert C, Marsch WC. Symmetric psychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome) Dermatology 1998;197:402-3.
60. Tidwell BH, Paterson TM, Burford B. Cimetidine-induced toxic epidermal necrolysis. Am J Health Syst Pharm 1998;55:163-4.
61. Horiuchi Y, Ikezawa K. Famotidine-induced erythema multiforme: cross-sensitivity with cimetidine. Ann Intern Med 1999;131:795.